logo
logo

DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program

Jan 24, 2024•over 1 year ago
PowellNanotechnology Research

Description

DNA Nanobots announced the closure of its pre-seed funding round, enabling the launch of its BioPharma Partner Program to streamline end-to-end custom biopharma solutions. The investment will support the development of therapeutics for cancer and rare diseases and facilitate partnerships with BioPharmaceutical companies.

Company Information

Company

DNA Nanobots

Location

Powell, Ohio, United States

About

DNA Nanobots is a platform biotechnology company pioneering the use of functionalized DNA nanoparticles to address challenges associated with targeted delivery of therapeutic payloads. They specialize in engineering custom cell-targeted solutions for partners to deliver drugs, nucleic acids, antibodies, and immunotherapies.

Related People